Abstract
Cardiac hypertrophy is a common finding in human patients with inborn errors of long-chain fatty acid oxidation. Mice with either very long-chain acyl-coenzyme A dehydrogenase deficiency (VLCAD-/-) or long-chain acyl-coenzyme A dehydrogenase deficiency (LCAD-/-) develop cardiac hypertrophy. Cardiac hypertrophy, initially measured using heart/body weight ratios, was manifested most severely in LCAD-/- male mice. VLCAD-/- mice, as a group, showed a mild increase in normalized cardiac mass (8.8% hypertrophy compared with all wild-type (WT) mice). In contrast, LCAD-/- mice as a group showed more severe cardiac hypertrophy (32.2% increase compared with all WT mice). On the basis of a clear male predilection, we analyzed the role of dietary plant estrogenic compounds commonly found in mouse diets because of soy or alfalfa components providing natural phytoestrogens or isoflavones in cardioprotection of LCAD-/- mice. Male LCAD-/- mice fed an isoflavone-free test diet had more severe cardiac hypertrophy (58.1% hypertrophy compared with WT mice fed the same diet). There were no significant differences in the female groups fed any of the diets. Echocardiography measurement performed on male LCAD-deficient mice fed a standard diet at the age of approximately 3 months confirmed the substantial cardiac hypertrophy in these mice compared with WT controls. Left ventricular (LV) wall thickness of the interventricular septum and posterior wall was remarkably increased in LCAD-/- mice compared with that of WT controls. Accordingly, the calculated LV mass after normalization to body weight was increased by about 40% in the LCAD-/- mice compared with WT mice. In summary, we found that metabolic cardiomyopathy, expressed as hypertrophy, developed in mice because of either VLCAD deficiency or LCAD deficiency; however, LCAD deficiency was the most profound and seemed to be attenuated either by endogenous estrogen (in females) or by phytoestrogens present in the diet as isoflavones (in males).
MeSH Terms
Acyl-CoA Dehydrogenase, Long-Chain/deficiency
Animals
Body Weight
Cardiomegaly/enzymology,pathology,prevention & control
Diet
Disease Models, Animal
Echocardiography
Female
Isoflavones/therapeutic use
Male
Mice
Mice, Knockout
Myocardium/pathology
Organ Size
Phytoestrogens/therapeutic use
Chemicals
Isoflavones
Phytoestrogens
Acyl-CoA Dehydrogenase, Long-Chain
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Cox Keith B
Department of Genetics, University of Alabama at Birmingham, USA.
Liu Jian
Tian Liqun
Barnes Stephen
Yang Qinglin
Wood Philip A
References (25)
25 references, click to expand
-
Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development.
Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):297-312
PMID: 19202595
-
Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.
Am J Hum Genet. 1996 May;58(5):971-8
PMID: 8651281
-
Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir.
FASEB J. 1996 Sep;10(11):1303-9
PMID: 8836044
-
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation.
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15592-7
PMID: 9861014
-
Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.
Pediatr Res. 1993 Jul;34(1):111-3
PMID: 8356011
-
Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.
J Clin Invest. 2002 Jul;110(2):259-69
PMID: 12122118
-
Substrate metabolism in the developing heart.
Semin Perinatol. 1996 Dec;20(6):542-63
PMID: 9090780
-
Fatty acid oxidation disorders.
Annu Rev Physiol. 2002;64:477-502
PMID: 11826276
-
Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones.
Curr Opin Pharmacol. 2009 Apr;9(2):139-45
PMID: 19157984
-
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
Endocrinology. 1998 Oct;139(10):4252-63
PMID: 9751507
-
Phytoestrogens and cardiovascular health.
J Am Coll Cardiol. 2000 May;35(6):1403-10
PMID: 10807439
-
Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.
Herz. 1995 Jun;20(3):156-68
PMID: 7543431
-
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.
Am J Hum Genet. 1999 Feb;64(2):479-94
PMID: 9973285
-
Chemical modification of isoflavones in soyfoods during cooking and processing.
Am J Clin Nutr. 1998 Dec;68(6 Suppl):1486S-1491S
PMID: 9848521
-
Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy.
Biochem Mol Med. 1996 Jun;58(1):59-65
PMID: 8809347
-
Dietary phytoestrogens increase metabolic resistance (cold tolerance) in long-chain acyl-CoA dehydrogenase-deficient mice.
J Nutr. 2004 May;134(5):1028-31
PMID: 15113940
-
Soybean isoflavones as an alternative to traditional hormone replacement therapy: are we there yet?
J Nutr. 2000 Mar;130(3):664S-5S
PMID: 10702606
-
Dietary isoflavones: biological effects and relevance to human health.
J Nutr. 1999 Mar;129(3):758S-767S
PMID: 10082786
-
Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets.
Hamostaseologie. 2008 Feb;28(1-2):85-8
PMID: 18278168
-
Soy diet worsens heart disease in mice.
J Clin Invest. 2006 Jan;116(1):209-16
PMID: 16395406
-
Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
Hum Mol Genet. 2001 Sep 15;10(19):2069-77
PMID: 11590124
-
Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.
Gend Med. 2008;5 Suppl A:S76-90
PMID: 18395685
-
Carnitine-acylcarnitine translocase deficiency.
Am J Med Sci. 1999 Jul;318(1):22-7
PMID: 10408757
-
Estrogen and coronary heart disease in women.
JAMA. 1991 Apr 10;265(14):1861-7
PMID: 2005736
-
Hormone replacement therapy, heart disease, and other considerations.
Annu Rev Public Health. 1998;19:55-72
PMID: 9611612